Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..2 of 2 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery
More
immuno-suppresant agent
More
Displaying 1..2 of 2 -
10
20
50
100
per page
Order by
number of views
addition date
development phase
Mar 2011 - 23 pages - $5,700
Nov 2010 - 1168 pages - $1,495
Sep 2011 - 95 pages - $3,500
Aug 2011 - 58 pages - $5,700
Sep 2011 - 87 pages - $5,700
Nov 2010 - 61 pages - $500
Jul 2011 - 54 pages - $3,800
Jan 2008 - 180 pages - $3,500
Oct 2011 - 131 pages - $3,500